Welding Engineering senior Jacob spent his summer at an internship with a medical device company.  Here is his report. Over the summer of 2013, I participated in a welding engineering internship program in Buffalo, New York, with Greatbatch Medical.  The scope of products there range from batteries used in medical devices, drilling rigs, in NASA […]

(United States Supreme Court) - Held that a mariner may not recover punitive damages on a claim that he was injured as a result of the unseaworthy condition of the vessel. After a hatch blew open and injured his hand, the deckhand filed suit under federal maritime law and sought punitive damages, among other things. However, the U.S. Supreme Court concluded that punitive damages are unavailable in unseaworthiness actions. Justice Alito delivered the opinion of the 6-3 Court.

(United States Federal Circuit) - Reversed and remanded where the plaintiff appealed from a judgment of the Court of Federal Claims which had dismissed his complaint for lack of subject-matter jurisdiction. In reversing and remanding, the Federal Circuit held that the court erred in concluding that it lacked jurisdiction.

#62ndGrammyAwards #GrammyAwards #GrammyNominations #MelissaB

Some call out people for not social distancing, others say there's plenty of room.

#62ndGrammyAwards #GrammyAwards #GrammyNominations #MelissaB

Our leaders are making difficult, life-and-death decisions without a complete picture of the severity of this threat or a timeline for how long it could last. It’s easy to second-guess the new rules, suggestions and regulations coming.

(United States Second Circuit) - Vacated & remanded. Finding the circumstances of these plaintiffs to be materially different from those in In re Aluminum Warehousing Antitrust Litig., the panel held that the district court erred in concluding the plaintiffs failed to establish antitrust standing.

(United States Second Circuit) - Vacated & remanded. Finding the circumstances of these plaintiffs to be materially different from those in In re Aluminum Warehousing Antitrust Litig., the panel held that the district court erred in concluding the plaintiffs failed to establish antitrust standing.

Rachel Hughes was thrilled Wednesday at the prospect of touching her husband, Rev. Terrence “Big T” Hughes, when they were briefly united on his release from the hospital where he’s battled COVID-19 for almost two months. “I was grateful he is alive and I could touch him, I didn’t know if I could touch him, […]

A toast to Brian Mullan. To Grandma Betty. To the nurses who selflessly, thanklessly, not only keep pulling their weight over the line. But ours, too.

Dr. Comilla Sasson has learned many lessons on the front lines of COVID-19, including how to stay positive

A toast to Brian Mullan. To Grandma Betty. To the nurses who selflessly, thanklessly, not only keep pulling their weight over the line. But ours, too.

A toast to Brian Mullan. To Grandma Betty. To the nurses who selflessly, thanklessly, not only keep pulling their weight over the line. But ours, too.

The actress found an important way to get involved.

We're not standing in his way!

It just got real.

It just got real.

He’s “been beaten, denied medical attention, and starved.”

See if Meek Mill is willing to go head-to-head

The legendary music producers broke the internet.

Could this be the next VERZUZ?

The battle is set to go down this Thursday at 8 PM ET.

Who would you pick?

Does she have a point?

The queen of Neo-Soul will be decided on May 9.

You may recall in the early days of the pandemic, that pharma giant Gilead Sciences -- which has been accused of price gouging and (just last year!) charging exorbitant prices on drug breakthroughs developed with US taxpayer funds -- was able to sneak through an orphan works designation for its drug remdesevir for COVID-19 treatment. As we pointed out, everything about this was insane, given that orphan works designations, which give extra monopoly rights to the holders (beyond patent exclusivity), are meant for diseases that don't impact a large population. Gilead used a loophole: since the ceiling for infected people to qualify for orphan drug status is 200,000, Gilead got in its application bright and early, before there were 200,000 confirmed cases (we currently have over 1.3 million). After the story went, er... viral, Gilead agreed to drop the orphan status, realizing the bad publicity it was receiving.

After a brief dalliance with chloroquine, remdesivir has suddenly been back in demand as the new hotness of possible COVID-19 treatments. Still, a close reading of the research might give one pause. There have been multiple conflicting studies, and Gilead's own messaging has been a mess.

On April 23, 2020, news of the study’s failure began to circulate. It seems that the World Health Organization (WHO) had posted a draft report about the trial on their clinical trials database, which indicated that the scientists terminated the study prematurely due to high levels of adverse side effects.

The WHO withdrew the report, and the researchers published their results in The Lancet on April 29, 2020.

The number of people who experienced adverse side effects was roughly similar between those receiving remdesivir and those receiving a placebo. In 18 participants, the researchers stopped the drug treatment due to adverse reactions.

But then...

However, also on April 29, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that their NIH trial showed that remdesivir treatment led to faster recovery in hospital patients with COVID-19, compared with placebo treatment.

“Preliminary results indicate that patients who received remdesivir had a 31% faster time to recovery than those who received placebo,” according to the press release. “Specifically, the median time to recovery was 11 days for patients treated with remdesivir compared with 15 days for those who received placebo.”

The mortality rate in the remdesivir treatment group was 8%, compared with 11.6% in the placebo group, indicating that the drug could improve a person’s chances of survival. These data were close to achieving statistical significance.

And then...

“In addition, there is another Chinese trial, also stopped because the numbers of new patients with COVID-19 had fallen in China so they were unable to recruit, which has not yet published its data,” Prof. Evans continues. “There are other trials where remdesivir is compared with non-remdesivir treatments currently [being] done and results from some of these should appear soon.”

Gilead also put out its own press release about another clinical trial, which seems more focused on determining the optimal length of remdesivir treatment. Suffice it to say, there's still a lot of conflicting data and no clear information on whether or not remdesevir actually helps.

Still, that hasn't stopped people from trying to figure out just how much Gilead will price gouge going forward:

The Institute for Clinical and Economic Review (ICER), which assesses effectiveness of drugs to determine appropriate prices, suggested a maximum price of $4,500 per 10-day treatment course based on the preliminary evidence of how much patients benefited in a clinical trial. Consumer advocacy group Public Citizen on Monday said remdesivir should be priced at $1 per day of treatment, since “that is more than the cost of manufacturing at scale with a reasonable profit to Gilead.”

Some Wall Street investors expect Gilead to come in at $4,000 per patient or higher to make a profit above remdesivir’s development cost, which Gilead estimates at about $1 billion.

So... we've got a range of $10 to $4,500 on a treatment that we don't yet know works, and which may or may not save lives. But, given that we're in the midst of a giant debate concerning things like "reopening the economy" -- something that can really only be done if the public is not afraid of dying (or at least becoming deathly ill) -- the value to the overall economy seems much greater than whatever amount Gilead wants to charge. It seems the right thing to do -- again, if it's shown that remdesevir actually helps -- is to just hand over a bunch of money to Gilead, say "thank you very much" and get the drug distributed as widely as possible. Though, again, it should be noted that a decent chunk of the research around remdesevir was not done or paid for by Gilead, but (yet again) via public funds to public universities, which did the necessary research. The idea that it's Gilead that should get to reap massive rewards for that seems sketchy at best. But the absolute worst outcome is one in which Gilead sticks to its standard operating procedure and prices the drug in a way that millions of Americans can't afford it, and it leads to a prolonging/expanding of the pandemic.

Zero-click remote-code exec hole found by Googler, updates emitted

Samsung has patched a serious security hole in its smartphones that can be exploited by maliciously crafted text messages to hijack devices.…

A review by ALLEN HALL (6). Excellently showcased what a computer could offer a gamer over a board game

For large electric power storage projects the cost of batteries has plummeted. 2008, when battery prices were 10 times higher than they are today. This advance is timely as photovoltaic electric power prices have dropped so far that in SoCal PV is causing a growing drop in mid-day demand and therefore a much bigger spike in evening demand. Therefore there's a growing need for a cheaper way to store power generated in mid day and deliver it in the evening. You can see how much solar power output surges each day in California by clicking on some of the Daily Renewables Watch links at the Cal ISO site (the organization that manages California's electric grid). The growing supply of wind...

"This is supposed to be a political party. In a healthy society, there would be a democratic process in the Democratic Party, by which elected people would be overseeing these issues by making sure there wasn’t just nepotism and insider dealing," Curry says. "That the political party itself — which is supposed to be the progressive party — has become mortgaged to a small group of Washington insiders, who raise money from large corporate PACs, [and] has become just a dead carcass of what it once was, is the most important piece of information that this contretemps over the data files has emphasized. It’s time for progressives in this country to stand up and demand a genuinely democratic process." Continue reading →

"And you know, we have to stop looking beyond this election cycle and see that this corporate driven ideology, you know, this commodification of the culture, this constant extracting of blood from us as citizens to pay what in essence were private debts of the banks which engaged in casino capitalism, has political consequences. History has taught us that. And Hillary Clinton is only going to further that process." Continue reading →

"The Attack Of The Dead Men", новое концертное видео группы SABATON, доступно для просмотра ниже. Эта песня взята со свежего альбома группы «The Great War». Материал был записан в ходе концерта группы в Москве, который состоялся 13 марта. Во время шоу на сцену неожиданно поднялся RADIO TAPOK и исполнил эту песню вместе с группой.

RADIO TAPOK – российский музыкант, получивший известность благодаря исполнению множества рок и метал кавер-версий на русском языке. Музыкант ранее уже выпускал свою кавер-версию «The Attack Of The Dead Men» по-русски.

Басист и мастермайнд SABATON Pär Sundström:

«Наша совместная работа с Radio Tapok - это особая честь для нас. Это очень талантливый музыкант, и его кавер на нашу песню «Attack Of The Dead Men» был принят так тепло, что мы не раздумывая решили пригласить его на сцену, чтобы вместе с нами исполнить эту песню на концертах в Москве и Санкт-Петербурге. А выступление получилось таким хорошим, что у нас не осталось другого выбора, кроме как выпустить нашу совместную работу в виде сингла!»

Песня «The Attack Of The Dead Men» посвящена событиям, связанным с крепостью Осовец во время Первой мировой войны, и знаменитой битве, где немецкие войска применили химическое оружие на основе хлора против российских защитников крепости, у которых не было средств от газовой атаки: они были вынуждены от отчаяния закрывать лица мокрой одеждой. Нападающие не ожидали, что кто-либо в крепости останется в живых, поэтому ответная атака стала абсолютно неожиданной и успешной. Кашляющие кровью защитники с лицами, обмотанными окровавленными тряпками, пошли вперед и обратили противника в бегство – так родилась знаменитая легенда об «атаке мертвецов».

Сейчас сингл доступен на цифровых платформах, а 10 июля 2020 будет выпущено специальное лимитированное издание на 12”-дюймовом виниле «The Attack Of The Dead Men' (Live in Moscow feat. RADIO TAPOK)». Планируется три вида: желто-зеленый винил с «брызгами» (специальное российское издание, подробнее по ссылке), цветной винил, пикчер диск. Все издания выходят ограниченным тиражом 666 шт.

Трек-лист:

Сторона А

'The Attack Of The Dead Men' (Live in Moscow feat. RADIO TAPOK)

Сторона B

'The Attack Of The Dead Men' (History Version)

Последний на сегодняшний день альбом SABATON «The Great War» был выпущен в 2019 году. Он занял первые места в чартах разных стран, включая Германию, Швейцарию и Швецию. Диск был прекрасно принят как поклонниками, так и критикой. Работа содержит ряд песен, которые стали выдающимися и хитовыми синглами: «Great War», «82nd All The Way», «The Red Baron» и «Fields of Verdun».

Недавно SABATON были вынуждены отложить часть концертов своего тура по России из-за пандемии коронавируса. Сейчас стали известны новые даты, в графике появились новые города.

"Мы успели отыграть девять концертов из 18-ти, пока этот чертов вирус не вынудил нас отменить все остальные. С тех самых пор мы работали днем и ночью, чтобы найти возможность вернуться в Россию и Беларусь и закончить начатое. Тур проходил фантастически до того момента, когда нам пришлось прервать его, и мы с нетерпением ждем своего возвращения" – говорит Pär Sundström.

Новые даты тура SABATON в России:

07.11.2020 Челябинск – Галактика Развлечений
08.11.2020 Екатеринбург - TeleClub
10.11.2020 Уфа – Тинькофф Холл
12.11.2020 Самара - Звезда
14.11.2020 Волгоград - VS Club
16.11.2020 Нижний Новгород - Milo
17.11.2020 Нижний Новгород - Milo
19.11.2020 Воронеж - Arena Hall
20.11.2020 Воронеж - Arena Hall
21.11.2020 Ростов-на-Дону - Кроп Arena
23.11.2020 Краснодар - Кроп Arena
24.11.2020 Ставрополь - Major #Sabaton #HeavyMetal #Heavy_Metal #PowerMetal #Power_Metal

В новом интервью с SiriusXM "Trunk Nation" у легендарного гитариста Tony Iommi спросили, доволен ли он тем, как прошёл прощальный тур BLACK SABBATH "The End", на что он ответил:

«Было здорово иметь возможность отправиться в последний тур. Честно говоря, я чувствовал себя неважно [из-за] этого, потому что в основном это был мой выбор, моя вина, потому что турне для меня в некоторой степени было в физическом плане не самой лучшей идеей. Я имею в виду, что приходилось возвращаться в часа утра после концерта — ты отыграл концерт, а потом летишь обратно в отель — это было много возвращений поздними ночами. Я находился в таких же условиях, как когда мне было 20. Несмотря на то, что мы путешествовали [на] лучших [условиях] — у нас был собственный самолет, у нас были потрясающие отели, и нас разместили в Нью-Йорке или Лос-Анджелесе на 10 дней, или где-то ещё, это было вот так. Выходили из отеля, летели на самолёте, давали концерт, возвращались, но к тому времени, как мы заканчивали, возвращались в отель и ложились спать, уже было три-четыре часа. А для меня это было трудно, и мой доктор сказал мне попробовать немного успокоиться. И в то время это казалось правильным.

Особенно после всего, что случилось с Ронни [Джеймсом Дио], мне очень понравился тот период [с HEAVEN & HELL], когда мы были снова с Дио, мы очень сблизились с этой группой, и это была отличная группа. А потом мы решили заново собрать SABBATH с Ozz'ом [Ozzy Osbourne'ом], и это было круто для завершения карьеры. Но я думаю, что если бы Ронни был жив, я бы, наверное, делал что-нибудь с ним сейчас».

Iommi также ответил на вопрос, возможны ли разовые выступления группы:

«Думаю, это было бы неплохо, ну если мы сможем это сделать. Сложность в том, по крайней мере с SABBATH, что это всё серьёзное предприятие, ты не можешь просто взять и отыграть, так как нужны техники, полная линейка оборудования и всё такое. И это должен быть год или полтора тура... Я не против чего-то такого, я просто хотел бы всё сделать иначе». #Black_Sabbath #BlackSabbath #HardRock #Hard_Rock #HeavyMetal #Heavy_Metal